Methods for bilateral renal neuromodulation
US-9131978-B2 · Sep 15, 2015 · US
US12343148B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12343148-B2 |
| Application number | US-202318358444-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 25, 2023 |
| Priority date | Oct 25, 2013 |
| Publication date | Jul 1, 2025 |
| Grant date | Jul 1, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An intravascular catheter for peri-vascular nerve activity sensing or measurement includes multiple needles advanced through supported guide tubes (needle guiding elements) which expand with open ends around a central axis to contact the interior surface of the wall of the renal artery or other vessel of a human body allowing the needles to be advanced though the vessel wall into the perivascular space. The system also may include means to limit and/or adjust the depth of penetration of the needles. The catheter also includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened needles are advanced to penetrate into the vessel wall. The addition of an injection lumen at the proximal end of the catheter and openings in the needles adds the functionality of ablative fluid injection into the perivascular space for an integrated nerve sending and ablation capability.
Opening claim text (preview).
What is claimed is: 1. A catheter for placement into a vessel of a human body comprising: a catheter body having a central lumen; at least two needle guiding elements comprising a curved shape adapted to advance outwardly from the catheter body toward an interior wall of a target vessel; at least two needles adapted to advance outwardly, guided by the at least two needle guiding elements to penetrate the interior wall of the target vessel, wherein the at least two needle guiding elements are configured to maintain their position against the interior wall of the target vessel as the at least two needles penetrate the interior wall of the target vessel to a target tissue; and a structure to reduce the internal volume of the catheter, wherein the structure extends the entire length of the catheter, wherein the structure comprises an insulated wire. 2. The catheter of claim 1 , wherein the structure comprises a wire. 3. The catheter of claim 1 , wherein the catheter is configured to inject a volume of between 0.15 ml and 0.6 ml of ablative fluid. 4. The catheter of claim 1 , wherein the internal volume of the catheter is less than 0.5 ml. 5. The catheter of claim 1 , wherein the catheter is configured to inject a volume of 0.3 ml of ablative fluid. 6. The catheter of claim 1 , wherein the structure is within the central lumen. 7. A catheter for placement into a target vessel of a human body comprising: a catheter body having a lumen for fluid delivery; at least two needle guiding elements comprising a curved shape adapted to advance outwardly from the catheter body toward the interior wall of the target vessel; at least two needles, each needle comprising a lumen for fluid delivery, the at least two needles adapted to advance outwardly, guided by the at least two needle guiding elements to penetrate the interior wall of the target vessel, wherein the at least two needle guiding elements are configured to maintain their position against the interior wall of the target vessel as the at least two needles penetrate the interior wall of the target vessel; and wherein an injection of about 0.6 ml is sufficient to fill the needed volume including the sympathetic nerves, where the fluid delivered comprises a hygroscopic fluid. 8. The catheter of claim 7 , where the fluid delivered comprises a lipophilic fluid. 9. The catheter of claim 7 , where the fluid delivered is configured to spread within the peri-vascular space. 10. The catheter of claim 7 , where the injection is configured such that the volume would not harm a kidney if accidentally discharged into a renal artery. 11. The catheter of claim 7 , further comprising a means to provide feedback on the effectiveness of ablation. 12. A method, comprising: providing a catheter having a catheter body with a proximal end, a distal end, and a first needle and a second needle; providing a first guiding element and a second guiding element, the first needle coaxial with the first guiding element and the second needle coaxial with the second guiding element; positioning the distal end of the catheter within a patient; advancing the first guiding element and the second guiding element outwardly from the catheter body toward a vessel wall; advancing the first needle through the first guiding element and into the vessel wall and advancing the second needle through the second guiding element and into the vessel wall, wherein the first guiding element and the second guiding element are configured to maintain their position against the vessel wall as the first needle and the second needle are advanced into the vessel wall; and injecting a volume of less than 1 ml of ablative fluid, wherein the success of ablation is assessed during the procedure. 13. The method of claim 12 , wherein the ablative fluid is ethanol. 14. The method of claim 12 , wherein the ablative fluid produces a multiplicity of ablation zones that intersect to form an ablative ring around the circumference of the target vessel. 15. The method of claim 12 , further comprising monitoring activity of sympathetic nerves being ablated. 16. The method of claim 12 , wherein the ablative fluid comprises a lipophilic fluid. 17. The method of claim 12 , wherein the ablative fluid comprises a hygroscopic fluid. 18. The method of claim 12 , wherein the ablative fluid is configured to spread within a peri-vascular space. 19. The catheter of claim 1 , wherein the catheter is configured to inject a volume of ablative fluid comprising ethanol.
Catheters · CPC title
Radiopaque markers visible in an X-ray image · CPC title
Evaluating the autonomic nervous system · CPC title
Assessing renal or kidney functions · CPC title
being one or more needles protruding from the distal tip and which are not used for injection nor for electro-stimulation, e.g. for fixation purposes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.